{"store":{"baseInfo":{"podcastTitle":"From Lab to Life","slug":"bellberryltd","podcastDescription":"Bellberry Limited is a national, independent, not for profit organisation that aims to protect the welfare of human research participants and to improve the quality, efficiency and effectiveness of research. Bellberry has launched this podcast series in celebration of its 20 years of operation.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17239578/BB_vertical_logo_n92nvs.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17239578/BB_vertical_logo_n92nvs_1200x628.jpg?s=93125a255b6daeb034332eb0daf8cac4&e=jpg","podcastUrl":"https://bellberryltd.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/bellberryltd/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pw/pbblog-vqanp-1070e1a?from=usersite","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":72,"gmtAdjustment":"GMT+09:30","useDaylightTime":0,"value":9.5,"text":"(GMT+09:30) Adelaide","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":null},"podcastDownloads":null,"totalEpisodes":12,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Bellberry Ltd","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-vqanp-1070e1a-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/from-lab-to-life/id1714566561","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-vqanp-1070e1a?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/6e6sCaPAyoHGszV8UDiuO0","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/dz2Ev2tzpuob","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-052NqVCGdsld","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2023 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://bellberryltd.podbean.com","apiCommonParams":{"t":"684c1f61","clientSignature":"476308d588ff6419e73ddf40ec0b165f","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb25699387-8k3hc","episode":{"id":"pb25699387","idTag":"8k3hc","title":"All About NAMs","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17239578/25-019_BbL_BellberryLabToLife_1920x1080px_ep12resize8vwzl_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog17239578/25-019_BbL_BellberryLabToLife_1920x1080px_ep12resize8vwzl_1200x628.jpg?s=b405a0bea0a75ba499286fd37eb4b960&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17239578/25-019_BbL_BellberryLabToLife_1920x1080px_ep12resize8vwzl.png","previewContent":null,"content":"

Worldwide there is growing focus on using NAMs (Non-Animal Models also known as Novel Approach Methods) in the development of therapeutics. In other words, removing animals from pre-clinical testing.

In this episode of From Lab to Life, we take you to a NAM symposium hosted by Bellberry and ASCEPT (Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists) held late in 2024.

","publishTimestamp":1744848835,"duration":1416,"mediaUrl":"https://mcdn.podbean.com/mf/web/vjrik4vyakq624in/Ep_12_All_About_NAMs_Edit02_2504147ratq.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-8k3hc-188243b","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-8k3hc-188243b","transcriptUrl":null,"permalink":"/e/all-about-nams/","downloadLink":"https://www.podbean.com/media/share/pb-8k3hc-188243b?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":50,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-8k3hc-188243b","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fbellberryltd.podbean.com%252Fe%252Fall-about-nams%252F&rts=b499c86c21cb2c7a67cafc4fbed359c7862ab4f7","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb25699387","idTag":"8k3hc","title":"All About NAMs","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17239578/25-019_BbL_BellberryLabToLife_1920x1080px_ep12resize8vwzl_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog17239578/25-019_BbL_BellberryLabToLife_1920x1080px_ep12resize8vwzl_1200x628.jpg?s=b405a0bea0a75ba499286fd37eb4b960&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17239578/25-019_BbL_BellberryLabToLife_1920x1080px_ep12resize8vwzl.png","previewContent":null,"content":"

Worldwide there is growing focus on using NAMs (Non-Animal Models also known as Novel Approach Methods) in the development of therapeutics. In other words, removing animals from pre-clinical testing.